Arcadia Biosciences, Inc.
RKDA
$2.88
-$0.0767-2.60%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -152.11% | -251.93% | 143.79% | 15.07% | -11.14% |
| Total Depreciation and Amortization | 8.92% | -24.88% | -8.33% | 2.70% | -16.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3,815.52% | 98.38% | -760.43% | -36.27% | -50.00% |
| Change in Net Operating Assets | -97.07% | -73.19% | 76.92% | 50.50% | -217.06% |
| Cash from Operations | -26.08% | 28.66% | 23.49% | 22.56% | -43.67% |
| Capital Expenditure | -- | 100.00% | 76.92% | -- | -- |
| Sale of Property, Plant, and Equipment | -104.44% | 24.14% | 752.94% | -76.71% | 1,360.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | -- | -- | -- |
| Cash from Investing | 1,297.22% | -96.12% | 115,975.00% | -92.31% | 940.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -- | -100.00% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | -- | -100.00% | -- | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 119.52% | -171.70% | 168.32% | 21.79% | -42.46% |